Oral s-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation

Scandinavian Journal of Rheumatology

Volumn 20, Issue 4, 1991, Pages 294-302

  Jacobsen, S ^a   Danneskiold Samsoe B ^a   Andersen, R Bach ^b  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Disease activity; Fibromyalgia; Isokinetic muscle strength; Management; S adenosylmethionine; Tender points

Indexed keywords

PLACEBO; S ADENOSYLMETHIONINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FIBROMYALGIA; HUMAN; MALE; MANAGEMENT; MUSCLE STRENGTH; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; AFFECT; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; GASTROINTESTINAL DISEASES; HUMAN; MALE; MIDDLE AGE; PAIN; S-ADENOSYLMETHIONINE;

EID: 0025784237     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749109096803     Document Type: Article

References (28)

1. Nonarticular rheumatism and psychogenic musculoskeletal syndromes
2. Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls
3. The American Rheumatism Association Committee on Rheumatologic Practice. A description of rheumatology practice
4. The private practice of rheumatology. The first 1.000 patients
5. Prevalence of primary and secondary fibrositis
6. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation
7. “Fibrositis” as a disorder of pain modulation
8. Fibromyalgia: Unusual historical aspects and new pathogenic insights
9. Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis
10. Muscle tissue oxygen pressure in primary fibromyalgia
11. Isometric and isokinetic muscle strength in patients with fibrositis syndrome
12. Interrelations between clinical parameters and muscle function in patients with primary fibromyalgia
13. Psychological factors associated with primary fibromyalgia syndrome
14. S-adenosylmethionine and affective disorder
15. S-adenosylmethionine in the treatment of osteoarthritis. Review of the clinical studies
16. Anti-inflammatory activity of S-adenosyl-L-methionine: interference with the eicosanoid system
17. Double-blind clinical trial of S-adenosylmethionine versus ibuprofen in the treatment of osteoarthritis
18. Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease
19. Double-blind controlled clinical trial of oral S-adenosylmethionine versus piroxicam in knee osteoarthritis
20. Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis
21. Evaluation of S-adenosylmethionine in primary fibromyalgia. A double-blind crossover study
22. A long-term (two years) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis
23. Assessment of depression: the depression inventory
24. The face scale: A brief, nonverbal method for assessing patient mood
25. Fibrositis: Symptom frequency and criteria for diagnosis. An evaluation of 291 rheumatic disease patients and 58 normal individuals
26. A polygraph evaluation of the effects of S-adenosyl-L-methionine (SAMe) on all-night sleep
27. Pharmacologic aspects of S-adenosylmethionine. Pharmacokinetics and pharmacodynamics